Skip to main content
Log in

RETRACTED ARTICLE: Hyaluronic Acid-Pluronic®F127-Laden Soft Contact Lenses for Corneal Epithelial Healing: In Vitro and In Vivo Studies

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

This article was retracted on 26 August 2022

This article has been updated

Abstract

Hyaluronic acid (HA) is widely used to treat various ocular diseases like dry eye syndrome, keratoconus, and other corneal epithelial injuries. The currently available eye drop solutions need frequent doses affecting the routine life style of patients. In this work, the silicone contact lens was designed to entrap HA and Pluronic®F127 to improve the wettability of the contact lens to treat various ocular diseases. The soaking method (HA-SM) was compared with the direct entrapment (DL-HA-PI) technique. The HA-Pluronic®F127-laden contact lenses (DL-HA-PI) showed acceptable optical transmittance with improved swelling (water content) properties. The in vitro release data showed high burst release with HA-SM contact lenses (12–36 h), while DL-HA-PI contact lenses showed prolong release up to 96 h. The in vivo release in the rabbit tear fluid showed high HA concentration (tear fluid) with DL-HA-PI contact lenses in comparison to the HA-SM contact lenses. The DL-HA-PI-3 batch with Pluronic®F127 showed more promising results in schirmer strip study in comparison to DL-HA-3 batch (without Pluronic®F127). The presence of Pluronic®F127 with HA showed high potential to improve hydration property of the contact lens. The corneal healing model showed reduction in the ocular inflammatory symptoms with DL-HA-PI-3 batch, thus demonstrating the potential of HA and Pluronic®F127 to be used in various ocular diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Change history

References

  1. Tani E, Katakami C, Negi A. Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits. Jpn J Ophthalmol. 2002;46(5):488–95.

    Article  CAS  Google Scholar 

  2. Gomes J, Amankwah R, Powell-Richards A, Dua H. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol. 2004;88(6):821–5.

    Article  CAS  Google Scholar 

  3. Bata AM, Witkowska KJ, Wozniak PA, Fondi K, Schmidinger G, Pircher N, et al. Effect of a matrix therapy agent on corneal epithelial healing after standard collagen cross-linking in patients with keratoconus: a randomized clinical trial. JAMA Ophthalmology. 2016;134(10):1169–76.

    Article  Google Scholar 

  4. Limberg MB, McCaa C, Kissling GE, Kaufman HE. Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes. Am J Ophthalmol. 1987;103(2):194–7.

    Article  CAS  Google Scholar 

  5. Bachu RD, Chowdhury P, Al-Saedi ZH, Karla PK, Boddu SH. Ocular drug delivery barriers—role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018;10(1):28–35.

    Article  Google Scholar 

  6. A. Desai, M. Shukla, F. Maulvi, K. Ranch, Ophthalmic and otic drug administration: novel approaches and challenges, Novel Drug Delivery Technologies, Springer2019, pp. 335–381.

  7. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58(11):1131–5.

    Article  CAS  Google Scholar 

  8. Ding S. Recent developments in ophthalmic drug delivery. Pharmaceut Sci Tech Today. 1998;1(8):328–35.

    Article  CAS  Google Scholar 

  9. Farkouh A, Frigo P, Czejka M. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin Ophthalmol. 2016;10:2433–41.

    Article  CAS  Google Scholar 

  10. H.J.J.o.d.t. Chen, Recent developments in ocular drug delivery, Journal of drug targeting 23(7–8) (2015) 597–604.

  11. Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm. 2004;269(1):1–14.

    Article  CAS  Google Scholar 

  12. Cholkar K, Patel SP, Vadlapudi AD, Mitra AK. Novel strategies for anterior segment ocular drug delivery. J Ocul Pharmacol Ther. 2013;29(2):106–23.

    Article  CAS  Google Scholar 

  13. Davis J, Gilger B, Robinson M. Novel approaches to ocular drug delivery. Curr Opin Mol Ther. 2004;6(2):195–205.

    CAS  PubMed  Google Scholar 

  14. K. Cholkar, A. Patel, A. Dutt Vadlapudi, A. K Mitra, Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery, Recent patents on nanomedicine 2(2) (2012) 82–95.

  15. Maulvi FA, Thakkar VT, Soni TG, Gandhi TR, Optimization of aceclofenac solid dispersion using Box-Behnken design: in-vitro and in-vivo evaluation, Current drug delivery 11(3) (2014) 380–391.

  16. Pandey S, Swamy SV, Gupta A, Koli A, Patel S, Maulvi F, et al. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon. J Microencapsul. 2018;35(3):259–71.

    Article  CAS  Google Scholar 

  17. Maulvi FA, Bodaa AM, Desai AR, Choksi HH, Ranch KM, Shah DO. Application of box-Behnken design in optimization of ibuprofen ternary solid dispersion. J Pharm Appl Sci. 2015;2(2):1–11.

    Google Scholar 

  18. Zhang X, Cao X, Qi P. Therapeutic contact lenses for ophthalmic drug delivery: major challenges. J Biomater Sci, Polymer Edition (just-accepted). 2020:1–16.

  19. Singh A, Li P, Beachley V, McDonnell P, Elisseeff JH. A hyaluronic acid-binding contact lens with enhanced water retention. Contact Lens Anterior Eye. 2015;38(2):79–84.

    Article  Google Scholar 

  20. Van Beek M, Jones L, Sheardown H. Hyaluronic acid containing hydrogels for the reduction of protein adsorption. Biomaterials. 2008;29(7):780–9.

    Article  Google Scholar 

  21. George M, Khong K, Maltseva I. Hyaluronic acid (HA) release of HA-containing lens care solutions with silicone hydrogel lenses. Contact Lens Anterior Eye. 2019;42(6):e17–8.

    Article  Google Scholar 

  22. Maulvi FA, Singhania SS, Desai AR, Shukla MR, Tannk AS, Ranch KM, et al. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis. Int J Pharm. 2018;548(1):139–50.

    Article  CAS  Google Scholar 

  23. Liu Y, Ren L, Wang Y. Crosslinked collagen–gelatin–hyaluronic acid biomimetic film for cornea tissue engineering applications. Mater Sci Eng C. 2013;33(1):196–201.

    Article  CAS  Google Scholar 

  24. Fiorica C, Palumbo FS, Pitarresi G, Bongiovì F, Giammona G. Hyaluronic acid and beta cyclodextrins films for the release of corneal epithelial cells and dexamethasone. Carbohydr Polym. 2017;166:281–90.

    Article  CAS  Google Scholar 

  25. Fiorica C, Senior RA, Pitarresi G, Palumbo FS, Giammona G, Deshpande P, et al. Biocompatible hydrogels based on hyaluronic acid cross-linked with a polyaspartamide derivative as delivery systems for epithelial limbal cells. Int J Pharm. 2011;414(1–2):104–11.

    Article  CAS  Google Scholar 

  26. Maulvi FA, Parmar RJ, Desai AR, Desai DM, Shukla MR, Ranch KM, et al. Tailored gatifloxacin Pluronic® F-68-loaded contact lens: addressing the issue of transmittance and swelling. Int J Pharm. 2020;119279.

  27. Desai AR, Maulvi FA, Desai DM, Shukla MR, Ranch KM, Vyas BA, et al. Multiple drug delivery from the drug-implants-laden silicone contact lens: addressing the issue of burst drug release. Mater Sci Eng C. 2020;110885.

  28. Maulvi FA, Parmar RJ, Shukla MR, Desai AR, Desai DT, Ranch KM, et al. Plackett-Burman design for screening of critical variables and their effects on the optical transparency and swelling of gatifloxacin-Pluronic-loaded contact lens. Int J Pharm. 2019;566:513–9.

    Article  CAS  Google Scholar 

  29. Kim T-H, Yae K-H, Kweon Y-S, Sung A. Study on the silicone contact lens using AA and BMA. J Korean Ophthalmic Opt Soc. 2006;11(3):259–65.

    Article  Google Scholar 

  30. Polse K, Decker M. Oxygen tension under a contact lens. Invest Ophthalmol Vis Sci. 1979;18(2):188–93.

    CAS  PubMed  Google Scholar 

  31. Moore L, Ferreira JT. Ultraviolet (UV) transmittance characteristics of daily disposable and silicone hydrogel contact lenses. Contact Lens Anterior Eye. 2006;29(3):115–22.

    Article  Google Scholar 

  32. Harris MG, Chin RS, Lee DS, Tam MH, Dobkins CE. Ultraviolet transmittance of the Vistakon disposable contact lenses. Contact Lens Anterior Eye. 2000;23(1):10–5.

    Article  CAS  Google Scholar 

  33. A. THAKUR, M.D.J.E.e.r. WILLCOX, Contact lens wear alters the production of certain inflammatory mediators in tears, 70(3) (2000) 255–259.

  34. Sack RA, Sathe S, Hackworth LA, Willcox MD, Holden BA, Morris CA. The effect of eye closure on protein and complement deposition on group IV hydrogel contact lenses: relationship to tear flow dynamics. Curr Eye Res. 1996;15(11):1092–100.

    Article  CAS  Google Scholar 

  35. Ciolino JB, Stefanescu CF, Ross AE, Salvador-Culla B, Cortez P, Ford EM, et al. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials. 2014;35(1):432–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lijun Cao.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1208/s12249-022-02400-y

Electronic supplementary material

ESM 1

(DOCX 1127 kb)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, N., Xu, X., Huang, C. et al. RETRACTED ARTICLE: Hyaluronic Acid-Pluronic®F127-Laden Soft Contact Lenses for Corneal Epithelial Healing: In Vitro and In Vivo Studies. AAPS PharmSciTech 21, 162 (2020). https://doi.org/10.1208/s12249-020-01714-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-020-01714-z

KEY WORDS

Navigation